A Late Diagnosis of Transthyretin Amyloidosis

Kristopher S Pfirman1,2, William Newton3, Collins Garst4

  • 1Cardiology, Geisinger Medical Center, Danville, USA.

Cureus
|February 28, 2022
PubMed

Insights

Cardiac amyloidosis, a rare disease from protein fibril buildup in the heart, stiffens the cardiac muscle. This case highlights late-stage transthyretin-related amyloidosis (ATTR) impacting heart function.

Area of Science:

  • Cardiology
  • Cardiovascular Diseases
  • Amyloidosis

Background:

  • Cardiac amyloidosis involves abnormal protein fibril deposition in the heart muscle.
  • This deposition leads to myocardial stiffening, reduced cardiac compliance, and diastolic dysfunction.
  • Systolic function is typically preserved until later stages of the disease.

Observation:

  • Presents a clinical case of advanced transthyretin-related amyloidosis (ATTR).
  • ATTR amyloidosis is a progressive infiltrative cardiomyopathy.
  • The disease progresses to affect systolic function in its late stages.

Findings:

  • ATTR amyloidosis can lead to significant cardiac dysfunction.
  • Late-stage disease progression affects the heart's ability to pump blood effectively.
  • The case underscores the importance of early diagnosis and management.

Implications:

  • Highlights the clinical presentation and progression of late-stage ATTR amyloidosis.
  • Emphasizes the need for timely diagnosis to prevent irreversible cardiac damage.
  • Informs clinical practice regarding the management of infiltrative cardiomyopathies.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
96
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K